Stay updated with breaking news from Matthew Powell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dostarlimab plus chemotherapy is the only immuno-oncology-based therapy that showed statistically significant and clinically meaningful survival benefit in the overall patient population.
Special education students are paired with a general education buddy for the event, he said, and they practice for three weeks leading up to it multiple days a week so those buddies can get to know one another.
Matthew Powell, MD, presents findings from a second interim analysis of part 1 from the ENGOT-EN6-NSGO/GOG-3031/RUBY trial investigating the combination of dostarlimab-gxly plus carboplatin/paclitaxel compared with placebo/chemotherapy in patients with primary advanced or recurrent endometrial cancer.
Global ad spending hits a staggering $5 trillion milestone in just five years, marking an unprecedented surge in the advertising industry.
Business seems to be picking up favourably in Vietnam’s real estate arena.